Table 1 Characteristics of patients with PAOD.

From: Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease

Characteristics

Case

Self-control

N

46,782

Age at first PAOD, mean ± SD, y

77.6 ± 6.7

 

Age at first PAOD, N (%)

67–69

5823 (12.5)

 

70–74

11,421 (24.4)

 

75–79

11,852 (25.3)

 

80–84

10,018 (21.4)

 

 ≥ 85

7668 (16.4)

 

Men, N (%)

25,043 (53.5)

 

Year of first PAOD, N (%)

2006

4121 (8.8)

 

2007

4339 (9.3)

 

2008

4651 (9.9)

 

2009

4723 (10.1)

 

2010

4809 (10.3)

 

2011

5274 (11.3)

 

2012

5357 (11.5)

 

2013

5273 (11.3)

 

2014

5481 (11.7)

 

2015

2754 (5.9)

 

Comorbid conditions, N (%)

DM

27,252 (58.3)

25,234 (53.9)

Hypertension

35,795 (76.5)

32,817 (70.2)

Hyperlipidemia

12,073 (25.8)

11,413 (24.4)

CKD severity

Early-stage CKD

34,476 (73.7)

37,809 (80.8)

Advanced CKD (pre-ESRD)

350 (0.8)

750 (1.6)

ESRD

11,956 (25.6)

8223 (17.6)

Charlson comorbidity index, N (%)

 ≤ 3

26,338 (56.3)

25,061 (53.6)

4–5

12,445 (26.6)

13,829 (29.6)

 > 5

7999 (17.1)

7892 (16.9)

Charlson comorbidity index, mean ± SD

3.4 ± 2.2

2.6 ± 2.0

  1. CKD chronic kidney disease, DM diabetes mellitus, ESRD end-stage renal disease, PAOD peripheral arterial occlusive disease, SD standard deviation.